In Depth 25 Mar 2024
Beyond Wegovy: Could Novo Nordisk’s new experimental weight loss pill be even better?
Discover how Novo Nordisk’s new experimental obesity pill, amycretin, could be even more efficient for weight loss than Wegovy.
Small molecules
- Latest Posts
In Depth 20 Mar 2024
Are molecular glues the key to undruggable targets?
As more biopharmas get sticky with molecular glue developers and venture capital interest grows, here is a review of the field.
Best in Biotech 7 Mar 2024
6 biotech companies tackling antibiotic resistance
Discover six antibiotic companies developing novel therapies in an attempt to overcome the global issue of antibiotic resistance.
In Depth 4 Mar 2024
ALS: how close are we to a cure?
Let us take a look at how the hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past few years.
Best in Biotech 29 Feb 2024
6 biotech companies making a difference in pediatric care
Take a closer look at six pediatric companies taking innovative approaches to tackle illnesses affecting children.
In Depth 15 Feb 2024
Turning the tide: recent advancements in childhood cancer research
As we observe International Childhood Cancer Day today, let us take a look at some of the recent advancements in childhood cancer research.
ADVERTISEMENT
